Skip to content

Clinical trials

Phase 1/2 Leukemia, Myeloid, Acute trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1/2 Country / region: China Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20164
20173
20183
20192
20203
202110
20228
20237
20249
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status26
Recruiting20
Not yet recruiting5
Completed4
Active, not recruiting3
Terminated3
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The First Affiliated Hospital of Soochow University5
Chinese PLA General Hospital3
Chongqing Precision Biotech Co., Ltd3
Institute of Hematology & Blood Diseases Hospital, China3
Shenzhen Geno-Immune Medical Institute3
Xuzhou Medical University3
Akeso2
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2
Essen Biotech2
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute63
Myelodysplastic Syndromes9
Recurrence8
Lymphoma6
Leukemia4
Multiple Myeloma4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Neoplasms3
Leukemia, Myeloid3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma3

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.